| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER, Director | C/O SPRUCE BIOSCIENCES, INC., 611 GATEWAY BOULEVARD, SUITE 740, SOUTH SAN FRANCISCO | /s/ Samir Gharib, Attorney-in-Fact | 05 Jan 2026 | 0001903669 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SPRB | Common Stock | Award | $21,248 | +4,690 | +33% | $4.53 | 19,004 | 31 Dec 2025 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | Shares acquired by the Reporting Person pursuant to the Issuer's 2020 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). The Reporting Person acquired the maximum shares allowable pursuant to Section 423 of the Internal Revenue Code. |